Clinical Trial Update: Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating sequential gemcitabine and cisplatin followed by pemetrexed and gemcitabine in patients with advanced or metastatic bladder cancer (t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Transitional Cell | Phase 1, Phase 2 | Status: COMPLETED